Cas:670271-04-2 3-thiophenecarboxylic acid, 2-amino-4-(2-furanyl)-, methyl ester manufacturer & supplier

Chemical Name:3-thiophenecarboxylic acid, 2-amino-4-(2-furanyl)-, methyl ester

CAS.NO:670271-04-2

Synonyms:methyl 2-amino-4-(2-furyl)thiophene-3-carboxylate(SALTDATA: FREE);METHYL 2-AMINO-4-(2-FURYL)THIOPHENE-3-CARBOXYLATE;2-AMINO-4-FURAN-2-YL-THIOPHENE-3-CARBOXYLIC ACID METHYL ESTER;METHYL 2-AMINO-4-(2-FURYL)-3-THIOPHENECARBOXYLATE

Molecular Formula:C₁₀H₉NO₃S

Molecular Weight:223.24800

HS Code:2934999090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:351.5ºC at 760 mmHg

Density:1.335g/cm3

Index of Refraction:1.604

PSA:93.70000

Exact Mass:223.03000

LogP:2.95810

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like methyl 2-amino-4-(2-furyl)thiophene-3-carboxylate(SALTDATA: FREE) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,METHYL 2-AMINO-4-(2-FURYL)-3-THIOPHENECARBOXYLATE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,METHYL 2-AMINO-4-(2-FURYL)-3-THIOPHENECARBOXYLATE Use and application,METHYL 2-AMINO-4-(2-FURYL)-3-THIOPHENECARBOXYLATE technical grade,usp/ep/jp grade.

Related News: A key publication in a preclinical model demonstrated rigosertib��s ability to block cellular signaling by targeting RAS effector pathways (Divakar, S.K., et al., 2016: ��A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.�� Cell 165, 643). 3-thiophenecarboxylic acid, 2-amino-4-(2-furanyl)-, methyl ester manufacturer At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world. 3-thiophenecarboxylic acid, 2-amino-4-(2-furanyl)-, methyl ester supplier At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world. 3-thiophenecarboxylic acid, 2-amino-4-(2-furanyl)-, methyl ester vendor There are however certain APIs that are unknown and so require additional substances that work in conjunction with the API to produce the required effect. 3-thiophenecarboxylic acid, 2-amino-4-(2-furanyl)-, methyl ester factory A key publication in a preclinical model demonstrated rigosertib��s ability to block cellular signaling by targeting RAS effector pathways (Divakar, S.K., et al., 2016: ��A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.�� Cell 165, 643).